iBio (IBIO) Finished Goods (2021)

iBio (IBIO) posted quarterly Finished Goods of $43000.0 for Q3 2021.

iBio (IBIO) Finished Goods (2021) Analysis & Trends

iBio (IBIO) has reported Finished Goods for 1 consecutive years, with $43000.0 the latest figure, recorded in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	iBio	175.21 Mn	175.21 Mn	-

Download Data

Date	Value
Sep 30, 2021	43,000.00